HY-N1673-100mg
|
MedChemexpress LLC
|
2,5-Dihydroxybenzaldehyde [CAS 1194-98-5]
|
|
COVID-19-immunoregulation
|
|
HY-N1673-500mg
|
MedChemexpress LLC
|
2,5-Dihydroxybenzaldehyde [CAS 1194-98-5]
|
|
COVID-19-immunoregulation
|
|
HY-W016867-100mg
|
MedChemexpress LLC
|
4-Chlorosalicylic acid [CAS 5106-98-9]
|
|
COVID-19-immunoregulation
|
|
HY-W016867-1mL
|
MedChemexpress LLC
|
4-Chlorosalicylic acid [CAS 5106-98-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10256A-10mg
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3]
|
|
COVID-19-immunoregulation
|
|
HY-10256A-100mg
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3]
|
|
COVID-19-immunoregulation
|
|
HY-10256A-5mg
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3]
|
|
COVID-19-immunoregulation
|
|
HY-10256A-50mg
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3]
|
|
COVID-19-immunoregulation
|
|
HY-10256A-1mL
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10256-10mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-100mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-5mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-50mg
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6]
|
|
COVID-19-immunoregulation
|
|
HY-10256-1mL
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15280-5mg
|
MedChemexpress LLC
|
GSK2292767 [CAS 1254036-66-2]
|
|
COVID-19-immunoregulation
|
|
HY-139423-10mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-100mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-25mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-5mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-50mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-1mL
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-125652-1mg
|
MedChemexpress LLC
|
Macrosphelide A [CAS 172923-77-2]
|
|
COVID-19-immunoregulation
|
|
HY-125652-5mg
|
MedChemexpress LLC
|
Macrosphelide A [CAS 172923-77-2]
|
|
COVID-19-immunoregulation
|
|
HY-N0928-25mg
|
MedChemexpress LLC
|
Mimosine [CAS 500-44-7]
|
|
COVID-19-immunoregulation
|
|
HY-N0928-50mg
|
MedChemexpress LLC
|
Mimosine [CAS 500-44-7]
|
|
COVID-19-immunoregulation
|
|